Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

Assiut University

Status: Completed

Conditions: Postoperative Pain

Treatments: Drug: Lidocaine; Drug: Nalbuphine

Study type: Interventional

Funder types: Other

Identifiers

NCT02678585

000087161

Details and patient eligibility

About

The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia

Enrollment: 106 patients

Sex: All

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult patients
• American Society of Anesthesiologists (ASA) physical status I-II
• age between 20 and 50 years old
• scheduled for elective unilateral short hand surgery

Exclusion criteria

• allergy to study medications
• body mass index > 35 kg/m2
• patients with sickle cell disease or Reynaud disease
• patient refusal

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

106 participants in 2 patient groups

Nalbuphine

Active Comparator group

Description:

53 patients received intravenous regional lidocaine plus Nalbuphine

Treatment:

Drug: Nalbuphine

Control group

Other group

Description:

53 patients received intravenous regional lidocaine

Treatment:

Drug: Lidocaine